RNS Number: 0790 L AorTech International PLC 03 September 2019 TR-1: Standard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 5270 J AorTech International PLC 19 August 2019 19 August 2019. AorTech International plc, the biomaterials IP and medical device development company, announces that all resolutions put to shareholders at its Annual General Meeting held earlier today, were duly passed.. AorTech International plc Tel: +44 7730 718296.
RNS Number: 9283 H AorTech International PLC 05 August 2019 5 August 2019. AorTech International plc, the biomaterials IP and medical device development company, announces that it s Annual Report and Accounts for the year ended 31 March 2019, have been posted to shareholders and are available on the Company's website at...
RNS Number: 0677 H AorTech International PLC 29 July 2019 TR-1: Standard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
AorTech Inter (AOR) 58p £8.6m AorTech International, the biomaterials IP and medical device development company, announced its audited final results for the year ended 31 March 2019. Transformational year: new Board in place executing an exciting, funded business plan Polymer IP business unit performing strongly: license fee and royalty income grew stongly increasing by 15% to £463k Year end cash balance: increased to £2,412k (2018: £422k) Medical device development business established: key partnership agreements signed for development of polymeric heart valves, vascular grafts and soft tissue patches Good progress made on R&D projects: design phase nearing completion and progression to prototype manufacture in current period Overheads remain tightly controlled: all R&D costs charged to profit Key milestones: expect to reach a number of key milestones in coming year
AorTech International Plc (AOR.L) Announced, in its audited final results for the year ended 31 March 2019, that its revenue stood at £0.46 million, compared to £0.40 million in the preceding year. The company’s diluted loss per share was 4.72p, compared to 0.61p.
RNS Number: 7516 F AorTech International PLC 17 July 2019. ·Polymer IP business unit performing strongly: license fee and royalty income grew stongly increasing by 15% to £463 k. ·Year end cash balance: increased to £2,412 k.
RNS Number: 7516 F AorTech International PLC 17 July 2019. ·Polymer IP business unit performing strongly: license fee and royalty income grew stongly increasing by 15% to £463 k. ·Year end cash balance: increased to £2,412 k.
RNS Number: 8039 E AorTech International PLC 08 July 2019. A second and final Price Monitoring Extension has been activated in this security. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 8024 E AorTech International PLC 08 July 2019. The auction call period has been extended in this security by 5 minutes. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 6808 C AorTech International PLC 19 June 2019 19 June 2019. AorTech announces the appointment of Shore Capital and Corporate Limited as its Nominated Adviser and Shore Capital Stockbrokers Limited as Broker, with immediate effect. This follows the acquisition of Stockdale Securities Limited by Shore Capital Markets Limited..
RNS Number: 6780 C AorTech International PLC 19 June 2019. AorTech International plc, the licensor of the world's leading long-term implantable biostable polymer and developer of medical devices utilising the key properties of Elast-Eon TM, makes the following disclosures pursuant to Rule 17 and Schedule Two paragraph of the AIM Rules for Companies in...
RNS Number: 4731 C AorTech International PLC 17 June 2019. Gordon Wright, Non-Executive Director of AorTech, was a director of Calmed UK Limited, which entered administration on 3 March 2009 and was dissolved on 9 December 2010. The Joint Administrators' Final Progress Report for the period 3 June 2011 to 23 November 2011 indicated that there was a shortfall to the...
RNS Number: 8724 Y AorTech International PLC 14 May 2019. ·Growth in polymer licensing revenue from £404 k to over £460 k. ·Strong cash position of £2.4 million as at 31 March 2019.
RNS Number: 0375 O AorTech International PLC 24 January 2019 24 January 2019. AorTech is pleased to provide an update on recent developments, an addition to its patent portfolio, the appointment of a new Company Secretary and the move of the Company's administration office.. AorTech's novel "Leaflet Builder" software utilising Computational Fluid Dynamics has...
While revenues from licensing our polymer technology continues to be earned in US$, with the new product development work all being undertaken in the UK, the switch to reporting in Sterling better reflects the currency of the primary economic environment in which the Company operates. In the six months ended 30 September 2018, revenues increased by 13 per cent...
RNS Number: 1101 E AorTech International PLC 15 October 2018 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 7699 Z AorTech International PLC 05 September 2018 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 2868 Z AorTech International PLC 30 August 2018 TR-1: S tandard form for notification of major holdings. This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.
RNS Number: 7264 Y AorTech International PLC 23 August 2018 AorTech International plc. AorTech International plc, the medical device development company and licensor of the world class bio-stable polymer, Elast-Eon TM, announces that all resolutions put to shareholders at its Annual General Meeting held earlier today, were duly passed..
Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -m
  • LOW
    -
  • CLOSE
    -
  • AVG VOL
    -
  • SHARES IN ISSUE
    14.69M

Classification

Market Indices-

Locations

HQ
Springfield House
23 Oatlands Drive
Level Two
Weybridge
KT13 9LZ
Watchlist